CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT is supported by aggressive capital deployment and a healthy acquisition pipeline, having completed $1.4 billion of deals YTD and $710 million of new investments in 3Q26, with management still targeting additional growth through 2027 and 2028. The LNT transaction is especially constructive because it adds $764 million of newly constructed UK care homes, with another $669 million expected in 2027, and the lease-up path should lift returns from low-5.0% cash yield to a higher stabilized operating yield over time. Despite some near-term dilution and a higher net debt to EBITDA ratio near 1.8x, the company’s expanding portfolio, stabilized tenant concerns, and FFO growth to $2.08/share in 2026 and $2.31/share in 2027 support a positive fundamental outlook.

CareTrust REIT is viewed negatively because its earnings growth appears vulnerable if the reimbursement backdrop tightens, especially through Medicaid cuts that would pressure operators and lease economics. Re-emergence of PACS-related concerns could further undermine confidence in the portfolio, raising the risk that growth stalls at its 2026 run-rate and forcing a valuation reset. In that downside case, a lower growth profile could pull the multiple back toward the 7-year historical average of about 14.0x, reflecting weaker fundamentals and reduced investor appetite.